Introduktion
Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Timothy P Walbert. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.
Gennemsnitlig handelsrentabilitet
Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.
Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.
Opdateringsfrekvens: Dagligt
Virksomheder med rapporterede insider-stillinger
SEC-registreringen viser, at Timothy P Walbert har rapporteret besiddelser eller handler i følgende virksomheder:
Sikkerhed | Titel | Senest indberettede beholdninger |
---|---|---|
US:MIRM / Mirum Pharmaceuticals, Inc. | Director | 5.703 |
US:BMRN / BioMarin Pharmaceutical Inc. | Director | 9.780 |
US:SGMT / Sagimet Biosciences Inc. | Director | 2.200 |
US:HZNP / Horizon Therapeutics Plc | Chairman, President and CEO, Director | 0 |
US:AUPH / Aurinia Pharmaceuticals Inc. | Director | 14.612 |
US:XCUR / Exicure, Inc. | Director | 50.000 |
US:ASRT / Assertio Holdings, Inc. | Director | 211.111 |
US:ZCOR / Zyla Life Sciences | Director | 0 |
US:SCMP / Sucampo Pharmaceuticals, Inc. | Director | 0 |
US:XOMA / XOMA Royalty Corporation | Director | 8.000 |
US:RPTP / Raptor Pharmaceutical Corp. | Director | 52.918 |
Sådan fortolkes diagrammerne
Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Timothy P Walbert. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.
I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.
Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.
Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.
Insiderkøb ASRT / Assertio Holdings, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg ASRT / Assertio Holdings, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb AUPH / Aurinia Pharmaceuticals Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg AUPH / Aurinia Pharmaceuticals Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb MIRM / Mirum Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg MIRM / Mirum Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SGMT / Sagimet Biosciences Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SGMT / Sagimet Biosciences Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb XCUR / Exicure, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg XCUR / Exicure, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb XOMAO / XOMA Royalty Corporation - Preferred Stock – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg XOMAO / XOMA Royalty Corporation - Preferred Stock – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderhandelshistorie
Denne tabel viser den komplette liste over insiderhandler foretaget af Timothy P Walbert som oplyst til Securities Exchange Commission (SEC).
Fil dato | Transdato | Form | Ticker | Sikkerhed | Kode | Aktier | Resterende aktier | Procent Lave om |
Del Pris |
Tran Værdi |
Tilbage Værdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-02 |
|
4 | MIRM |
Mirum Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 5.703 | 5.703 | |||||
2025-05-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6.650 | 9.780 | 212,46 | ||||
2025-03-07 | 3/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
416 | ||||||||
2025-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 3.130 | 3.130 | |||||
2024-04-03 | 3 | SGMT |
Sagimet Biosciences Inc.
Series A Common Stock |
2.200 | ||||||||
2023-10-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
D - Sale to Issuer | -49.935 | 0 | -100,00 | 116,50 | -5.817.428 | ||
2023-10-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
D - Sale to Issuer | -100.300 | 0 | -100,00 | 116,50 | -11.684.950 | ||
2023-10-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
D - Sale to Issuer | -107.739 | 0 | -100,00 | 116,50 | -12.551.594 | ||
2023-10-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
D - Sale to Issuer | -616.772 | 0 | -100,00 | 116,50 | -71.853.938 | ||
2023-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -97.461 | 616.493 | -13,65 | 113,24 | -11.036.484 | 69.811.667 | |
2023-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 219.995 | 713.954 | 44,54 | ||||
2023-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -46.365 | 493.959 | -8,58 | 113,80 | -5.276.337 | 56.212.534 | |
2023-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 104.498 | 540.324 | 23,98 | ||||
2023-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -6.729 | 49.656 | -11,93 | 113,80 | -765.760 | 5.650.853 | |
2023-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 15.185 | 56.385 | 36,86 | ||||
2022-06-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -9.800 | 435.826 | -2,20 | 92,74 | -908.852 | 40.418.503 |
2022-06-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -15.200 | 445.626 | -3,30 | 92,08 | -1.399.616 | 41.033.242 |
2022-06-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 460.826 | 5,74 | 22,14 | 553.500 | 10.202.688 | |
2022-06-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.700 | 435.549 | -0,62 | 94,46 | -255.042 | 41.141.959 |
2022-06-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -3.800 | 438.249 | -0,86 | 93,21 | -354.198 | 40.849.189 |
2022-06-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -18.500 | 442.049 | -4,02 | 92,04 | -1.702.740 | 40.686.190 |
2022-05-20 |
|
4 | AUPH |
Aurinia Pharmaceuticals Inc.
Stock Option (right to buy) |
A - Award | 14.612 | 14.612 | |||||
2022-05-20 |
|
4 | AUPH |
Aurinia Pharmaceuticals Inc.
Restricted Stock Unit |
A - Award | 8.733 | 8.733 | |||||
2022-05-20 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 767.565 | -3,15 | ||||
2022-05-20 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -25.000 | 460.549 | -5,15 | 90,00 | -2.250.000 | 41.449.410 |
2022-05-20 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 485.549 | 5,43 | 22,14 | 553.500 | 10.750.055 | |
2022-05-13 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -17.600 | 792.565 | -2,17 | ||||
2022-05-13 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -17.600 | 460.549 | -3,68 | 90,00 | -1.584.000 | 41.449.410 |
2022-05-13 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 17.600 | 478.149 | 3,82 | 22,14 | 389.664 | 10.586.219 | |
2022-05-10 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -7.400 | 810.165 | -0,91 | ||||
2022-05-10 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -5.000 | 460.549 | -1,07 | 91,11 | -455.550 | 41.960.619 |
2022-05-10 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.400 | 465.549 | -0,51 | 90,33 | -216.792 | 42.053.041 |
2022-05-10 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 7.400 | 467.949 | 1,61 | 22,14 | 163.836 | 10.360.391 | |
2022-05-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -3.450 | 460.549 | -0,74 | 97,43 | -336.134 | 44.871.289 |
2022-05-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -7.608 | 463.999 | -1,61 | 96,62 | -735.085 | 44.831.583 |
2022-05-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -13.942 | 471.607 | -2,87 | 95,38 | -1.329.788 | 44.981.876 |
2022-04-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 817.565 | -2,97 | ||||
2022-04-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -1.087 | 485.549 | -0,22 | 109,39 | -118.907 | 53.114.205 |
2022-04-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -1.800 | 486.636 | -0,37 | 107,94 | -194.292 | 52.527.490 |
2022-04-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -5.700 | 488.436 | -1,15 | 107,02 | -610.014 | 52.272.421 |
2022-04-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -16.413 | 494.136 | -3,21 | 106,10 | -1.741.419 | 52.427.830 |
2022-04-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 510.549 | 5,15 | 22,14 | 553.500 | 11.303.555 | |
2022-04-08 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 842.565 | -2,88 | ||||
2022-04-08 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -16.687 | 485.549 | -3,32 | 112,72 | -1.880.959 | 54.731.083 |
2022-04-08 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -8.313 | 502.236 | -1,63 | 111,70 | -928.562 | 56.099.761 |
2022-04-08 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 510.549 | 5,15 | 22,14 | 553.500 | 11.303.555 | |
2022-04-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -35.480 | 485.549 | -6,81 | 105,52 | -3.743.850 | 51.235.130 |
2022-04-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -14.520 | 521.029 | -2,71 | 104,61 | -1.518.937 | 54.504.844 |
2022-03-25 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 867.565 | -2,80 | ||||
2022-03-25 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -25.000 | 535.549 | -4,46 | 109,37 | -2.734.340 | 58.574.922 |
2022-03-25 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 560.549 | 4,67 | 22,14 | 553.500 | 12.410.555 | |
2022-03-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 892.565 | -2,72 | ||||
2022-03-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -6.662 | 535.549 | -1,23 | 101,38 | -675.394 | 54.293.958 |
2022-03-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -18.338 | 542.211 | -3,27 | 100,77 | -1.847.920 | 54.638.602 |
2022-03-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 560.549 | 4,67 | 22,14 | 553.500 | 12.410.555 | |
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -1.208 | 535.549 | -0,23 | 93,57 | -113.033 | 50.111.320 |
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.900 | 536.757 | -0,54 | 92,50 | -268.250 | 49.650.022 |
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -19.000 | 539.657 | -3,40 | 91,54 | -1.739.260 | 49.400.202 |
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -26.892 | 558.657 | -4,59 | 90,41 | -2.431.306 | 50.508.179 |
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 917.565 | -2,65 | ||||
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -25.000 | 585.549 | -4,09 | 92,51 | -2.312.662 | 54.167.089 |
2022-03-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 610.549 | 4,27 | 22,14 | 553.500 | 13.517.555 | |
2022-02-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 942.565 | -2,58 | ||||
2022-02-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -5.337 | 585.549 | -0,90 | 97,74 | -521.638 | 57.231.559 |
2022-02-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -19.663 | 590.886 | -3,22 | 97,32 | -1.913.603 | 57.505.026 |
2022-02-11 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 610.549 | 4,27 | 22,14 | 553.500 | 13.517.555 | |
2022-02-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs) |
M - Exercise | -9.087 | 0 | -100,00 | ||||
2022-02-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -3.767 | 40.923 | -8,43 | 94,33 | -355.341 | 3.860.267 | |
2022-02-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 9.087 | 44.690 | 25,52 | ||||
2022-01-31 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -11.206 | 585.549 | -1,88 | 92,42 | -1.035.659 | 54.116.439 |
2022-01-31 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -74.253 | 596.755 | -11,07 | 91,94 | -6.826.821 | 54.865.655 |
2022-01-31 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -14.541 | 671.008 | -2,12 | 90,95 | -1.322.504 | 61.028.178 |
2022-01-31 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 967.565 | -2,52 | ||||
2022-01-31 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -25.000 | 685.549 | -3,52 | 90,00 | -2.250.000 | 61.699.410 |
2022-01-31 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 710.549 | 3,65 | 22,14 | 553.500 | 15.731.555 | |
2022-01-24 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs) |
M - Exercise | -20.336 | 0 | -100,00 | ||||
2022-01-24 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -9.009 | 685.549 | -1,30 | 86,42 | -778.558 | 59.245.145 | |
2022-01-24 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 20.336 | 694.558 | 3,02 | ||||
2022-01-14 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 992.565 | -2,46 | ||||
2022-01-14 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -25.000 | 674.222 | -3,58 | 90,02 | -2.250.412 | 60.691.105 |
2022-01-14 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 699.222 | 3,71 | 22,14 | 553.500 | 15.480.775 | |
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -4.657 | 9.314 | -33,33 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -3.386 | 3.387 | -49,99 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -34.928 | 69.857 | -33,33 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -46.466 | 23.200 | -66,70 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -44.266 | 44.270 | -50,00 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -58.055 | 58.055 | -50,00 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -58.035 | 0 | -100,00 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -3.636 | 35.603 | -9,27 | 101,84 | -370.290 | 3.625.810 | |
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 8.043 | 39.239 | 25,78 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -174.906 | 674.222 | -20,60 | 101,84 | -17.812.427 | 68.662.768 | |
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 152.896 | 849.128 | 21,96 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 241.750 | 696.232 | 53,19 | ||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
A - Award | 21.424 | 21.424 | |||||
2022-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
A - Award | 73.796 | 73.796 | |||||
2022-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -25.000 | 1.017.565 | -2,40 | ||||
2022-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -7.522 | 454.482 | -1,63 | 108,55 | -816.513 | 49.334.021 |
2022-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -67.478 | 462.004 | -12,74 | 108,02 | -7.288.974 | 49.905.672 |
2022-01-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 25.000 | 529.482 | 4,96 | 22,14 | 553.500 | 11.722.731 | |
2021-12-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -13.487 | 504.482 | -2,60 | 103,54 | -1.396.444 | 52.234.066 |
2021-12-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -15.875 | 517.969 | -2,97 | 102,62 | -1.629.092 | 53.153.979 |
2021-12-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -20.638 | 533.844 | -3,72 | 101,48 | -2.094.344 | 54.174.489 |
2021-11-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -637 | 554.482 | -0,11 | 120,09 | -76.497 | 66.587.743 |
2021-11-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -9.733 | 555.119 | -1,72 | 119,36 | -1.161.731 | 66.259.004 |
2021-11-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -6.829 | 564.852 | -1,19 | 118,46 | -808.963 | 66.912.368 |
2021-11-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -7.801 | 571.681 | -1,35 | 117,31 | -915.135 | 67.063.898 |
2021-11-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | 100.300 | 100.300 | |||||
2021-11-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | -100.300 | 31.196 | -76,28 | ||||
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -600 | 579.482 | -0,10 | 112,01 | -67.206 | 64.907.779 |
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -18.940 | 580.082 | -3,16 | 110,80 | -2.098.552 | 64.273.086 |
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -30.460 | 599.022 | -4,84 | 109,96 | -3.349.382 | 65.868.459 |
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | 110.502 | 131.496 | 526,35 | ||||
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | -110.502 | 629.482 | -14,93 | ||||
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | 107.739 | 107.739 | |||||
2021-10-01 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | -107.739 | 739.984 | -12,71 | ||||
2021-08-27 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -7.435 | 1.042.565 | -0,71 | ||||
2021-08-27 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 7.435 | 847.723 | 0,88 | 22,14 | 164.611 | 18.768.587 | |
2021-07-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.434 | 840.288 | -0,29 | 102,57 | -249.655 | 86.188.340 |
2021-07-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -22.566 | 842.722 | -2,61 | 101,65 | -2.293.834 | 85.662.691 |
2021-07-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
A - Award | 69.668 | 69.668 | |||||
2021-07-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -15.432 | 865.288 | -1,75 | 102,50 | -1.581.780 | 88.692.020 | |
2021-07-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 34.833 | 880.720 | 4,12 | ||||
2021-07-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | -5.000 | 845.887 | -0,59 | ||||
2021-07-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -1.408 | 850.887 | -0,17 | 94,78 | -133.450 | 80.647.070 |
2021-07-02 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -23.592 | 852.295 | -2,69 | 93,80 | -2.212.930 | 79.945.271 |
2021-06-16 |
|
4 | AUPH |
Aurinia Pharmaceuticals Inc.
Stock Option (right to buy) |
A - Award | 31.347 | 31.347 | |||||
2021-06-04 |
|
4 | XCUR |
EXICURE, INC.
Stock Option (right to buy) |
A - Award | 50.000 | 50.000 | |||||
2021-06-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -17.524 | 875.887 | -1,96 | 92,21 | -1.615.888 | 80.765.540 |
2021-06-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -7.476 | 893.411 | -0,83 | 91,00 | -680.316 | 81.300.401 |
2021-04-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -20.872 | 899.838 | -2,27 | 95,14 | -1.985.762 | 85.610.587 |
2021-04-30 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -4.128 | 920.710 | -0,45 | 94,15 | -388.651 | 86.684.846 |
2021-03-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.312 | 924.838 | -0,25 | 91,98 | -212.649 | 85.063.177 |
2021-03-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -24.663 | 927.150 | -2,59 | 91,29 | -2.251.488 | 84.639.616 |
2021-02-19 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
A - Award | 69.666 | 69.666 | |||||
2021-02-19 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
A - Award | 18.868 | 18.868 | |||||
2021-02-19 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -4.179 | 951.813 | -0,44 | 87,17 | -364.283 | 82.969.539 | |
2021-02-19 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 9.433 | 955.992 | 1,00 | ||||
2021-02-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs) |
M - Exercise | -9.087 | 9.087 | -50,00 | ||||
2021-02-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -2.950 | 19.945 | -12,88 | 77,04 | -227.268 | 1.536.563 | |
2021-02-03 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 9.087 | 22.895 | 65,81 | ||||
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -3.871 | 946.559 | -0,41 | 76,90 | -297.692 | 72.793.416 |
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -7.452 | 950.430 | -0,78 | 76,25 | -568.225 | 72.471.523 |
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
M - Exercise | -2.575 | 0 | -100,00 | ||||
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
M - Exercise | -20.330 | 20.336 | -49,99 | ||||
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -755 | 13.808 | -5,18 | 77,43 | -58.460 | 1.069.153 | |
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 2.575 | 14.563 | 21,48 | ||||
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -9.007 | 957.882 | -0,93 | 77,43 | -697.412 | 74.168.803 | |
2021-01-22 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 20.330 | 966.889 | 2,15 | ||||
2021-01-15 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.299 | 946.559 | -0,24 | 79,10 | -181.851 | 74.872.817 |
2021-01-15 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -127.504 | 948.858 | -11,85 | 78,26 | -9.978.756 | 74.259.809 |
2021-01-15 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -81.401 | 1.076.362 | -7,03 | 77,26 | -6.289.285 | 83.162.957 |
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -3.386 | 6.773 | -33,33 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -58.055 | 116.110 | -33,33 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -152.967 | 0 | -100,00 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -58.035 | 58.035 | -50,00 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -1.597 | 11.988 | -11,76 | 73,28 | -117.028 | 878.481 | |
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 3.386 | 13.585 | 33,20 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -337.380 | 1.157.763 | -22,57 | 73,28 | -24.723.206 | 84.840.873 | |
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 492.294 | 1.495.143 | 49,09 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 269.057 | 1.002.849 | 36,67 | ||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
A - Award | 13.971 | 13.971 | |||||
2021-01-06 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
A - Award | 104.785 | 104.785 | |||||
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -1.300 | 733.792 | -0,18 | 75,75 | -98.470 | 55.582.029 |
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -22.120 | 735.092 | -2,92 | 75,19 | -1.663.123 | 55.268.921 |
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -14.718 | 757.212 | -1,91 | 73,86 | -1.087.139 | 55.931.161 |
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -18.263 | 771.930 | -2,31 | 72,75 | -1.328.721 | 56.161.613 |
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -11.262 | 790.193 | -1,41 | 71,57 | -805.991 | 56.551.979 |
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -42.337 | 801.455 | -5,02 | 70,76 | -2.995.969 | 56.714.803 |
2020-08-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
G - Gift | -5.000 | 843.792 | -0,59 | ||||
2020-06-08 |
|
4 | XCUR |
EXICURE, INC.
Stock Option (right to buy) |
A - Award | 21.693 | 21.693 | |||||
2020-05-22 |
|
4 | ASRT |
Assertio Holdings, Inc.
Common Stock |
A - Award | 211.111 | 211.111 | |||||
2020-05-22 |
|
4 | ASRT |
Assertio Holdings, Inc.
Common Stock |
A - Award | 49.143 | 49.143 | |||||
2020-05-21 |
|
4 | ZCOR |
Zyla Life Sciences
Common Stock |
D - Sale to Issuer | -26.953 | 0 | -100,00 | ||||
2020-04-24 |
|
4 | ZCOR |
Zyla Life Sciences
Restricted Stock Units |
M - Exercise | 6.667 | 13.333 | 100,02 | ||||
2020-04-24 |
|
4 | ZCOR |
Zyla Life Sciences
Common Stock |
F - Taxes | -952 | 5.715 | -14,28 | 1,75 | -1.666 | 10.001 | |
2020-04-24 |
|
4 | ZCOR |
Zyla Life Sciences
Common Stock |
M - Exercise | 6.667 | 6.667 | 1,75 | 11.667 | 11.667 | ||
2020-03-05 |
|
4 | ZCOR |
Zyla Life Sciences
Common Stock |
A - Award | 13.620 | 13.620 | |||||
2020-02-21 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -93.864 | 847.743 | -9,97 | 35,23 | -3.306.829 | 29.865.986 |
2020-02-21 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
A - Award | 96.864 | 96.864 | |||||
2020-02-21 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -21.457 | 941.607 | -2,23 | 36,06 | -773.739 | 33.954.348 | |
2020-02-21 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 48.432 | 963.064 | 5,30 | ||||
2020-02-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs) |
M - Exercise | -9.086 | 18.174 | -33,33 | ||||
2020-02-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -2.668 | 9.150 | -22,58 | 34,49 | -92.019 | 315.584 | |
2020-02-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 9.086 | 11.818 | 332,58 | ||||
2020-01-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
A - Award | 2.575 | 2.575 | |||||
2020-01-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs) |
A - Award | 40.666 | 40.666 | |||||
2020-01-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -891 | 2.732 | -24,59 | 38,25 | -34.081 | 104.499 | |
2020-01-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 2.574 | 3.623 | 245,38 | ||||
2020-01-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -9.006 | 914.632 | -0,98 | 38,25 | -344.480 | 34.984.674 | |
2020-01-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 20.329 | 923.638 | 2,25 | ||||
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -84.886 | 903.309 | -8,59 | 35,57 | -3.019.395 | 32.130.701 |
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -152.966 | 152.967 | -50,00 | ||||
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
M - Exercise | -58.034 | 116.070 | -33,33 | ||||
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
F - Taxes | -168.319 | 988.195 | -14,55 | 36,10 | -6.076.316 | 35.673.840 | |
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
A - Award | 168.523 | 1.156.514 | 17,06 | ||||
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 211.000 | 987.991 | 27,16 | ||||
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
A - Award | 10.159 | 10.159 | |||||
2020-01-07 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU) |
A - Award | 174.165 | 174.165 | |||||
2019-10-17 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -204.682 | 0 | -100,00 | ||||
2019-10-17 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy) |
M - Exercise | -107.187 | 0 | -100,00 | ||||
2019-10-17 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -320.174 | 776.991 | -29,18 | 28,02 | -8.970.283 | 21.768.879 |
2019-10-17 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 204.682 | 1.097.165 | 22,93 | 7,61 | 1.557.630 | 8.349.426 | |
2019-10-17 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
M - Exercise | 107.187 | 892.483 | 13,65 | 2,40 | 257.249 | 2.141.959 | |
2019-09-04 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -2.500 | 785.296 | -0,32 | 28,00 | -70.000 | 21.988.288 |
2019-08-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -1.984 | 787.796 | -0,25 | 28,00 | -55.552 | 22.058.288 |
2019-08-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -11.000 | 789.780 | -1,37 | 28,01 | -308.110 | 22.121.738 |
2019-08-23 |
|
4 | HZNP |
Horizon Therapeutics Public Ltd Co
Ordinary Shares |
S - Sale | X | -45.836 | 800.780 | -5,41 | 28,00 | -1.283.408 | 22.421.840 |
2019-07-22 |
|
4 | XCUR |
EXICURE, INC.
Stock Option (right to buy) |
A - Award | 43.386 | 43.386 | |||||
2019-04-24 |
|
4 | ZCOR |
Egalet Corp
Common Stock |
A - Award | 20.000 | 20.000 | |||||
2019-03-25 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -125.000 | 0 | -100,00 | ||||
2019-03-25 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -55.375 | 844.246 | -6,16 | 26,84 | -1.486.265 | 22.659.563 | |
2019-03-25 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 125.000 | 899.621 | 16,14 | ||||
2019-02-22 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -74.657 | 774.621 | -8,79 | 21,54 | -1.608.112 | 16.685.336 | |
2019-02-22 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
A - Award | 168.521 | 849.278 | 24,75 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -75.000 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -58.133 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -29.666 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -10.000 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -20.000 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -667 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
D - Sale to Issuer | -1.328 | 0 | -100,00 | ||||
2019-02-04 |
|
4 | EGLT |
Egalet Corp
Common Stock |
D - Sale to Issuer | -150 | 0 | -100,00 | ||||
2019-02-01 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units (RSU) |
A - Award | 27.260 | 27.260 | |||||
2019-01-08 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units (RSU) |
M - Exercise | -152.966 | 305.933 | -33,33 | ||||
2019-01-08 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -68.080 | 680.757 | -9,09 | 20,39 | -1.388.151 | 13.880.635 | |
2019-01-08 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 152.966 | 748.837 | 25,67 | ||||
2019-01-08 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units (RSU) |
A - Award | 174.104 | 174.104 | |||||
2018-11-21 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -18.318 | 204.682 | -8,21 | ||||
2018-11-21 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -31.483 | 107.187 | -22,70 | ||||
2018-11-21 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 18.318 | 595.871 | 3,17 | 7,61 | 139.400 | 4.534.578 | |
2018-11-21 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 31.483 | 577.553 | 5,77 | 2,40 | 75.559 | 1.386.127 | |
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -196.794 | 0 | -100,00 | ||||
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -107.219 | 0 | -100,00 | ||||
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -104.334 | 0 | -100,00 | ||||
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
S - Sale | X | -408.347 | 546.070 | -42,78 | 21,54 | -8.795.794 | 11.762.348 |
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 196.794 | 954.417 | 25,98 | 4,96 | 976.098 | 4.733.908 | |
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 107.219 | 757.623 | 16,48 | 12,94 | 1.387.414 | 9.803.642 | |
2018-11-16 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 104.334 | 650.404 | 19,11 | 5,20 | 542.537 | 3.382.101 | |
2018-06-05 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -83.353 | 0 | -100,00 | ||||
2018-06-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
S - Sale | X | -83.353 | 546.070 | -13,24 | 16,17 | -1.348.218 | 8.832.573 |
2018-06-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 83.353 | 629.423 | 15,26 | 10,43 | 869.372 | 6.564.882 | |
2018-05-15 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
A - Award | 75.000 | 75.000 | |||||
2018-05-07 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units (RSU) |
A - Award | 458.899 | 458.899 | |||||
2018-03-27 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -125.000 | 125.000 | -50,00 | ||||
2018-03-27 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -55.375 | 543.700 | -9,24 | 13,86 | -767.498 | 7.535.682 | |
2018-03-27 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 125.000 | 599.075 | 26,37 | ||||
2018-02-13 |
|
4 | SCMP |
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy) |
D - Sale to Issuer | -10.000 | 0 | -100,00 | 7,70 | -77.000 | ||
2018-02-13 |
|
4 | SCMP |
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A |
D - Sale to Issuer | -5.130 | 0 | -100,00 | 18,00 | -92.340 | ||
2018-01-03 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -49.500 | 0 | -100,00 | ||||
2018-01-03 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -23.626 | 474.075 | -4,75 | 15,02 | -354.863 | 7.120.606 | |
2018-01-03 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 49.500 | 497.701 | 11,04 | ||||
2017-06-12 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
A - Award | 58.133 | 58.133 | |||||
2017-06-05 |
|
4 | SCMP |
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy) |
A - Award | 10.000 | 40.000 | 33,33 | ||||
2017-06-05 |
|
4 | SCMP |
Sucampo Pharmaceuticals, Inc.
Common Stock |
A - Award | 5.130 | 14.930 | 52,35 | ||||
2017-05-22 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 8.000 | 8.000 | |||||
2017-03-24 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -125.000 | 250.000 | -33,33 | ||||
2017-03-24 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -57.125 | 446.721 | -11,34 | 14,56 | -831.740 | 6.504.258 | |
2017-03-24 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 125.000 | 503.846 | 32,99 | ||||
2017-01-04 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -49.500 | 49.500 | -50,00 | ||||
2017-01-04 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -32.175 | 0 | -100,00 | ||||
2017-01-04 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -37.703 | 378.846 | -9,05 | 16,18 | -610.035 | 6.129.728 | |
2017-01-04 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 81.675 | 416.549 | 24,39 | ||||
2016-08-19 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -8.330 | 138.670 | -5,67 | ||||
2016-08-19 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 8.330 | 334.874 | 2,55 | 2,40 | 19.992 | 803.698 | |
2016-08-02 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 60.532 | 60.532 | |||||
2016-08-02 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 48.246 | 129.314 | 59,51 | ||||
2016-06-17 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
A - Award | 29.666 | 29.666 | 4,98 | 147.737 | 147.737 | ||
2016-06-17 |
|
4 | EGLT |
Egalet Corp
Common Stock (Right to Buy) |
A - Award | 10.000 | 10.000 | 12,08 | 120.800 | 120.800 | ||
2016-06-06 |
|
4 | SCMP |
Sucampo Pharmaceuticals, Inc.
Common Stock |
A - Award | 9.800 | 9.800 | |||||
2016-05-31 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -2.800 | 0 | -100,00 | ||||
2016-05-31 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 2.800 | 81.068 | 3,58 | ||||
2016-03-24 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -125.000 | 375.000 | -25,00 | ||||
2016-03-24 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -57.125 | 324.493 | -14,97 | 16,32 | -932.280 | 5.295.726 | |
2016-03-24 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 125.000 | 381.618 | 48,71 | ||||
2016-01-05 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -49.500 | 99.000 | -33,33 | ||||
2016-01-05 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -32.175 | 32.175 | -50,00 | ||||
2016-01-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -30.845 | 256.618 | -10,73 | 21,67 | -668.411 | 5.560.912 | |
2016-01-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 81.675 | 287.463 | 39,69 | ||||
2015-12-14 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -2.082 | 196.794 | -1,05 | ||||
2015-12-14 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 2.082 | 205.788 | 1,02 | 4,96 | 10.327 | 1.020.708 | |
2015-12-10 |
|
4/A | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -33.211 | 0 | -100,00 | ||||
2015-12-10 |
|
4/A | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -15.178 | 203.706 | -6,93 | 20,40 | -309.631 | 4.155.602 | |
2015-12-10 |
|
4/A | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 33.211 | 218.884 | 17,89 | ||||
2015-12-09 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -33.211 | 0 | -100,00 | ||||
2015-12-09 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -15.178 | 203.706 | -6,93 | 21,40 | -324.809 | 4.359.308 | |
2015-12-09 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 33.211 | 218.884 | 17,89 | ||||
2015-10-14 |
|
4 | SCMP |
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
2015-06-01 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -2.800 | 0 | -100,00 | ||||
2015-06-01 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -2.800 | 0 | -100,00 | ||||
2015-06-01 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 2.800 | 78.268 | 3,71 | ||||
2015-06-01 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 2.800 | 78.268 | 3,71 | ||||
2015-05-22 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 36.873 | 36.873 | 3,39 | 124.999 | 124.999 | ||
2015-05-22 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 36.873 | 72.668 | 103,01 | ||||
2015-05-08 |
|
4 | HZNP |
Horizon Pharma plc
Performance Share Units (PSU) |
A - Award | 2.025.000 | 2.025.000 | |||||
2015-05-08 |
|
4 | HZNP |
Horizon Pharma plc
Performance Share Units (PSU) |
A - Award | 45.000 | 675.000 | 7,14 | ||||
2015-05-08 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 1.650.000 | 1.650.000 | |||||
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -18.079 | 198.876 | -8,33 | ||||
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -24.603 | 104.334 | -19,08 | ||||
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -38.348 | 83.353 | -31,51 | ||||
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
M - Exercise | -5.568 | 107.219 | -4,94 | ||||
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 18.079 | 175.125 | 11,51 | 4,96 | 89.672 | 868.620 | |
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 24.603 | 157.046 | 18,58 | 5,20 | 127.936 | 816.639 | |
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 38.348 | 132.443 | 40,75 | 10,43 | 399.970 | 1.381.380 | |
2015-05-05 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 5.568 | 94.095 | 6,29 | 12,94 | 72.050 | 1.217.589 | |
2015-03-25 |
|
4 | HZNP |
Horizon Pharma plc
Performance Share Units (PSU) |
A - Award | 630.000 | 630.000 | |||||
2015-03-25 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
A - Award | 500.000 | 500.000 | |||||
2015-03-25 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 1.050.000 | 1.050.000 | |||||
2015-01-26 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -33.210 | 33.211 | -50,00 | ||||
2015-01-26 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
F - Taxes | -14.065 | 33.205 | -29,75 | 12,99 | -182.704 | 431.333 | |
2015-01-26 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
M - Exercise | 33.210 | 47.270 | 236,20 | ||||
2015-01-26 |
|
4/A | HZNP |
Horizon Pharma plc
Restricted Stock Units |
M - Exercise | -32.175 | 96.525 | -25,00 | ||||
2015-01-26 |
|
4/A | HZNP |
Horizon Pharma plc
Common Stock |
M - Exercise | 32.175 | 180.672 | 21,67 | ||||
2015-01-06 |
|
4 | HZNP |
Horizon Pharma plc
Restricted stock units |
M - Exercise | -49.500 | 148.500 | -25,00 | ||||
2015-01-06 |
|
4 | HZNP |
Horizon Pharma plc
Restricted stock units |
M - Exercise | -32.175 | 64.350 | -33,33 | ||||
2015-01-06 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary shares |
F - Taxes | -26.353 | 88.527 | -22,94 | 12,80 | -337.318 | 1.133.146 | |
2015-01-06 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary shares |
M - Exercise | 81.675 | 114.880 | 245,97 | ||||
2014-11-20 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
S - Sale | -150.000 | 14.060 | -91,43 | 12,05 | -1.807.500 | 169.423 | |
2014-11-17 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -4.498 | 0 | -100,00 | ||||
2014-11-17 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 4.498 | 35.795 | 14,37 | ||||
2014-10-01 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
A - Award | 20.000 | 20.000 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
D - Sale to Issuer | -198.000 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
D - Sale to Issuer | -223.000 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
D - Sale to Issuer | -96.525 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
D - Sale to Issuer | -147.000 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
D - Sale to Issuer | -66.421 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
D - Sale to Issuer | -216.955 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
D - Sale to Issuer | -112.787 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
D - Sale to Issuer | -128.937 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
D - Sale to Issuer | -121.701 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Common Stock |
D - Sale to Issuer | -164.060 | 0 | -100,00 | ||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
A - Award | 198.000 | 198.000 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 223.000 | 223.000 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
A - Award | 96.525 | 96.525 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 147.000 | 147.000 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Restricted Stock Units |
A - Award | 66.421 | 66.421 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 216.955 | 216.955 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 112.787 | 112.787 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 128.937 | 128.937 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Stock Option (Right to Buy) |
A - Award | 121.701 | 121.701 | |||||
2014-09-22 |
|
4 | HZNP |
Horizon Pharma plc
Ordinary Shares |
A - Award | 164.060 | 164.060 | |||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 7.000 | 7.000 | 4,73 | 33.110 | 33.110 | ||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 31.297 | 21,32 | ||||
2014-06-11 |
|
4 | EGLT |
Egalet Corp
Stock Option (Right to Buy) |
A - Award | 667 | 667 | |||||
2014-05-29 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -2.800 | 2.800 | -50,00 | ||||
2014-05-29 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -2.800 | 2.800 | -50,00 | ||||
2014-05-29 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 2.800 | 25.797 | 12,18 | ||||
2014-05-29 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 2.800 | 25.797 | 12,18 | ||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 11.600 | 11.600 | 3,87 | 44.892 | 44.892 | ||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 20.197 | 71,20 | ||||
2014-05-21 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common stock |
S - Sale | X | -31.742 | 148.930 | -17,57 | 12,94 | -410.741 | 1.927.154 |
2014-03-17 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Stock options (right to buy) |
M - Exercise | X | -5.521 | 52.918 | -9,45 | |||
2014-03-17 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
S - Sale | X | -5.521 | 0 | -100,00 | 15,22 | -84.018 | |
2014-03-17 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
M - Exercise | X | 5.521 | 5.521 | 3,33 | 18.385 | 18.385 | |
2014-02-11 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Stock options (right to buy) |
A - Award | -50.000 | 50.000 | -50,00 | ||||
2014-01-15 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Stock options (right to buy) |
M - Exercise | X | -5.520 | 58.439 | -8,63 | |||
2014-01-15 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
S - Sale | X | -5.520 | 0 | -100,00 | 15,06 | -83.113 | |
2014-01-15 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
M - Exercise | X | 5.520 | 5.520 | 3,33 | 18.382 | 18.382 | |
2014-01-10 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Restricted stock units |
A - Award | 198.000 | 198.000 | |||||
2014-01-10 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Employee stock options (right to buy) |
A - Award | 223.000 | 223.000 | |||||
2013-12-09 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Restricted stock units |
M - Exercise | -33.210 | 66.421 | -33,33 | ||||
2013-12-09 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
S - Sale | -12.124 | 148.497 | -7,55 | 6,79 | -82.322 | 1.008.295 | |
2013-12-09 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
M - Exercise | 33.210 | 160.621 | 26,07 | ||||
2013-12-09 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
A - Award | 43.290 | 127.411 | 51,46 | ||||
2013-11-15 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -4.498 | 1.102 | -80,32 | ||||
2013-11-15 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 4.498 | 11.797 | 61,62 | ||||
2013-11-15 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Stock options (right to buy) |
M - Exercise | X | -5.521 | 63.959 | -7,95 | |||
2013-11-15 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
S - Sale | X | -5.521 | 0 | -100,00 | 12,44 | -68.655 | |
2013-11-15 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
M - Exercise | X | 5.521 | 5.521 | 3,33 | 18.385 | 18.385 | |
2013-09-17 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Stock options (right to buy) |
M - Exercise | X | -5.520 | 69.480 | -7,36 | |||
2013-09-17 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
S - Sale | X | -5.520 | 0 | -100,00 | 14,07 | -77.668 | |
2013-09-17 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Common Stock |
M - Exercise | X | 5.520 | 5.520 | 3,33 | 18.382 | 18.382 | |
2013-05-29 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -2.800 | 5.600 | -33,33 | ||||
2013-05-29 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 2.800 | 7.299 | 62,24 | ||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
A - Award | 8.400 | 8.400 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 11.600 | 11.600 | 4,13 | 47.908 | 47.908 | ||
2013-01-03 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Restricted stock units |
A - Award | 128.700 | 128.700 | |||||
2013-01-03 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Employee stock options (right to buy) |
A - Award | 147.000 | 147.000 | |||||
2013-01-03 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common stock |
S - Sale | X | -20.749 | 78.661 | -20,87 | 2,36 | -48.968 | 185.640 |
2012-12-12 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Restricted stock units |
M - Exercise | -33.211 | 99.631 | -25,00 | ||||
2012-12-12 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
S - Sale | -10.301 | 99.410 | -9,39 | 2,28 | -23.486 | 226.655 | |
2012-12-12 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
M - Exercise | 33.211 | 109.711 | 43,41 | ||||
2012-11-15 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
M - Exercise | -4.499 | 8.996 | -33,34 | ||||
2012-11-15 |
|
4 | XOMA |
XOMA Corp
Common Shares |
M - Exercise | 4.499 | 4.499 | |||||
2012-09-28 |
|
4 | RPTP |
Raptor Pharmaceutical Corp
Stock options (right to buy) |
A - Award | 50.000 | 230.000 | 27,78 | ||||
2012-07-27 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
A - Award | 42.000 | 70.000 | 150,00 | ||||
2012-05-25 |
|
4 | XOMA |
XOMA Corp
Restricted Stock Units |
A - Award | 8.400 | 8.400 | |||||
2012-05-25 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Share Option (right to buy) |
A - Award | 11.600 | 11.600 | 2,36 | 27.376 | 27.376 | ||
2012-03-07 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
A - Award | 28.000 | 28.000 |